Enocitabine

Enocitabine

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	IV
ATC code	none
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
CAS Number	55726-47-1 Y
PubChem CID	71734
ChemSpider	64778 N
UNII	9YVR68W306
KEGG	D01633 Y
ChEMBL	ChEMBL2106589 N
CompTox Dashboard (EPA)	DTXSID6046682
Chemical and physical data
Formula	C31H55N3O6
Molar mass	565.796 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(N/C/1=N/C(=O)N(\C=C\1)[C@@H]2O[C@@H]([C@@H](O)[C@@H]2O)CO)CCCCCCCCCCCCCCCCCCCCC
InChI InChI=1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 N Key:SAMRUMKYXPVKPA-VFKOLLTISA-N N
NY (what is this?)  (verify)

Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.

Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.

Synthesis

ChemDrug Synthesis: Patent:

• cytarabine [147-94-4] (1)
• Palmitic anhydride [623-65-4] (2)
• cytidine [65-46-3] (4)
• N-Hexadecanoylcytidine [60107-19-9] (5)

References

• (in Japanese) Sunrabin